Список литературы

Поставить закладку

Swartz J. etal. Vaccination and allergic sensitization in early childhood – the ALADDIN birth cohort//EClinicalMedicine. – 2018. – Т. 4. – С. 92–98.
Соловьева И. Л. и др. Напряженность специфического иммунитета у детей с аллергическими заболеваниями при вакцинации против гепатита//Эпидемиология и вакцинопрофилактика. – 2005. – № 1.
Основы вакцинопрофилактики у детей с хронической патологией/Под ред. М. П. Костинова. М.: Медицина для всех. 2002. 320 с.
Магаршак О. О., Костинов М. П. Проблемы вакцинации детей с аллергическими заболеваниями//Лечащий врач. – 2008. – № 9. – С. 44–48.
Kowalski M. L. et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement//World Allergy Organization Journal. – 2016. – Т. 9. – № 1. – С. 33.
Dreskin S. C. et al. International Consensus (ICON): allergic reactions to vaccines // World Allergy Organization Journal. – 2016. – Т. 9. – № 1. – С. 32.
Таточенко В. К., Озерецковский Н. А., Соколова А. Ф. и др. Иммунопрофилактика: Справочник/Под ред. В. К. Таточенко, Н. А. Озерецковского. М.: Издательство Остоженка инвест, 1998. 155 с.
McNeil M. M. et al. Risk of anaphylaxis after vaccination in children and adults // Journal of Allergy and Clinical Immunology. – 2016. – Т. 137. – № 3. – С. 868–878.
Simons F. E., Ardusso L. R., Bilo M. B., Cardona V., Ebi-sawa M., El-Gamal Y. M. et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014; 7 (9): 1–19. DOI: 10.1186/1939–4551–7-9.
Muraro A., Roberts G., Worm M., Bilo M. B., Brockow K., Fernández, Rivas M. et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69 (8): 1026–1045. DOI: 10.1111/all.12437.
Nilsson L. et al. Vaccination and allergy: EAACI position paper, practical aspects // Pediatric Allergy and Immunology. – 2017. – Т. 28. – № 7. – С. 628–640.
Echeverri a-Zudaire L. A., Ortigosa-del Castillo L., Alonso-Lebrero E., AlvaresGarcia F. J., Cortes-Alvares N. et al. Consensus document on the approach to children with allergic reactions after vaccination or allergy to vaccine components. Allergol Immunopathol (Madr) 2015; 43: 304–325. DOI:10.1016/j.aller. 2015.01.004.
Пампура А. Н., Конюкова Н. Г. Анафилаксия к пищевым продуктам у детей раннего возраста. Росвестнперинатол и педиатр 2011; 56 (5): 76–84. [Pampura A. N., Konyu-kova N. G. Anaphylaxis on food products in young children. Ros vestn perinatol i pediatr 2011; 56 (5): 76–84. (in Russ).
Popa V. T., Lerner S. A. Biphasic systemic anaphylactic reactions: three illustrative cases. Ann Allergy 1984; 53: 151–155.
Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95 (3): 217–226.
Helbling A., Hurni T., Mueller U. R., Pichler W. J. Incidence of anaphylaxis with circulatory symptoms: A study over a 3-year period comprising 940000 inhabitants of the swiss canton bern. Clin Exp Allergy 2004; 34: 285–290.
Calvani M., Cardinale F., Martelli A., Muraro A., Pucci N., Savino F. et al. Italian Society of Pediatric Allergy and Immunology (SIAIP) Anaphylaxis’ Study Group. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22 (8): 813–819.
Вакцинопрофилактика. Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок. Методические указания (утв. Главным государственным санитарным врачом РФ) 09.01.2002.
Федеральные клинические рекомендации по проведению аллерген-специфической иммунотерапии, Москва, 2013 г.
E. Alvarez-Cuesta, J. Bousquet, G. W. Canonica, S. R. Durham, H.-J. Malling, E. Valovirta EEACI, Immunotherapy Task Force ALLERGY (2006): 61 Suppl 82.
Алексеев А. Оценка эффективности вакцинации населения г. Москвы вакциной «Ваксигрипп». В сб.: Вакцинопрофилактика гриппа. –1998. – с. 60–70.
Альбицкий В. Ю., Баранов А. А., Камаев И. А., Огнева М. Л. Часто болеющие дети. Нижний Новгород: Изд-во НГМА. 2003. 180 с.
Ельшина Т. А., Горбунов М. А., Бектемиров Т. А. и др. Оценка безвредности и эффективности гриппозной тривалентной профилактической полимерсубъединичной вакцины Гриппол при введении детям школьного возраста//Журн. Микробиология 2000 г., № 2: 50–54.
Global Initiative forAsthma. Global Strategy forAsthma Management and Prevention, 2016.Available at: http://ginasthma .org/wp-content/uploads/2016/04/GINA2016-main-report_tracked.pdf.
Протасов А. Д., Жестков А. В., Костинов М. П., Корымасов Е. А., Штейнер М. Л., Тезиков Ю. В., Липатов И. С., Решетникова В. П., Лаврентьева Н. Е. Отдаленные результаты клинической эффективности разных схем вакцинации против пневмококковой инфекции и возможный механизм действия вакцинации у больных бронхиальной астмой. Пульмонология. 2018;28 (2):193–199. https://doi.org/10.18093/0869–0189–2018–28–2-193–199.
Murphy K. et al. Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or nonsteroidal conventional asthma therapy//International journal of clinical practice. – 2006. – Т. 60. – № 12. – С. 1548–1557.
Костинов, М. П., et al. Вакцинация детей с аллергическими заболеваниями. Эффективная фармакотерапия, 17 (2012): 15–19.
Leung D. Y. M. Infection in atopic dermatitis//Currentopinion in pediatrics. – 2003. – Т. 15. – № 4. – С. 399–404.
Umaretiya P. J. et al. Asthma and risk of breakthrough varicella infection in children//Allergy and asthma proceedings. – OceanSide Publications, 2016. – Т. 37. – № 3. – С. 207.
Capili C. R., Hettinger A., Rigelman-Hedberg N., et al. Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol 129:957–963, 2012.
Yoo K. H., Jacobson R., Poland G., et al. Asthma status and waning of measles antibody levels concentrations after measles immunization. Pediatr Infect Dis J 33:1016–1022, 2014.
Vaccines and immunizations [Электронный ресурс]: www.cdc.gov/vaccines (дата обращения 01.10.2018).
Kattan J. D. et al. Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow’s milk allergy//Journal of Allergy and Clinical Immunology. – 2011. – Т. 128. – № 1. – С. 215–218
Nakayama T., Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004//Vaccine. – 2007. – Т. 25. – № 3. – С. 570–576.
Иммунопрофилактика – 2018: справочник, 13-е издание, расширенное/В. К. Таточенко, Н. А. Озерцовский. М.: Боргес, 2018. – 272 с.
Beveridge M. G. et al. Local vaccine site reactions and contact allergy to aluminum//Pediatric dermatology. – 2012. – Т. 29. – № 1. – С. 68–72.
Bergfors E., Trollfors B. Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines – prognosis and outcome after booster vaccination//European journal of pediatrics. – 2013. – Т. 172. – № 2. – С. 171–177.
Parisi C. A. S. et al. Hypersensitivity reactions to the Sabin vaccine in children with cow’s milk allergy//Clinical & Experimental Allergy. – 2013. – Т. 43. – № 2. – С. 249–254.
Sakaguchi M., Toda M., Ebihara T., Irie S., et al. IgE antibody to fish gelatin (type I collagen) in patients with fish allergy//Journal of allergy and clinical immunology. – 2000. – Т. 106. – № 3. – С. 579–584.
Sakaguchi M., Nakayama T., Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines//Journal of allergy and clinical immunology. – 1996. – Т. 98. – № 6. – С. 1058–1061.
Sakai Y. et al. Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix//Biological and Pharmaceutical Bulletin. – 1998. – Т. 21. – № 4. – С. 330–334.
Sakaguchi M., Nakayama T., Inouye S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines // Journal of allergy and clinical immunology. – 1996. – Т. 98. – № 6. – С. 1058–1061.
Kumagai T. et al. Gelatin-specific humoral and cellular immune responses in children with immediate-and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines//Journal of allergy and clinical immunology. – 1997. – Т. 100. – № 1. – С. 130–134.
Sakaguchi M. et al. Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines//Vaccine. – 1997. – Т. 15. – № 2. – С. 121–122.
Worm M. et al. Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine//Acta dermato-venereologica. – 2000. – Т. 80. – № 3.
Kuno-Sakai H., Kimura M. Removal of gelatin from live vaccines and DTaP – an ultimate solution for vaccine-related gelatin allergy//Biologicals. – 2003. – Т. 31. – № 4. – С. 245–249.
Ozaki T. et al. Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan//Vaccine. – 2005. – Т. 23. – № 10. – С. 1205–1208.
Nagel G., Hennig R., Broeker M. New gelatine-free TBE vaccines with improved safety profile // Klinische Padiatrie. – 2006. – Т. 218. – № 6. – С. 379; discussion 379.
Рубан А. П., Пампура А. Н. Анафилаксия и вакцинация: риски и реалии//Российский вестник перинатологии и педиатрии. – 2018. – Т. 63. – № 4. – С. 15–22.
Bohlke K. et al. Risk of anaphylaxis after vaccination of children and adolescents//Pediatrics. – 2003. – Т. 112. – № 4. – С. 815–820.
Назарова Е. В. Аллергические реакции на вакцины//Эффективная фармакотерапия. – 2016. – № 24. – С. 10–13.
Plotkin S. History of vaccination//Proceedings of the National Academy of Sciences. – 2014. – Т. 111. – № 34. – С. 12283–12287.
Xepapadaki P. et al. Incidence and natural history of hen’s egg allergy in the first 2 years of life – the EuroPrevall birth cohort study//Allergy. – 2016. – Т. 71. – № 3. – С. 350–357.
Panesar S. S., Javad S., de Silva D., Nwaru B. I., Hickstein L., Muraro A., Roberts G., Worm M., Bilo M. B., Cardona V., Dubois A. E. J., Dunn Galvin A., Eigenmann P., Fernandez-Rivas M., Halken S., Lack G., Niggemann B., Santos A. F., VliegBoerstra B. J., Zolkipli Z. Q.& Sheikh A. on behalf of the EAACI Food Allergy and Anaphylaxis Group. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68: 1353–1361.
User guide molecular allergy.
Burks A. W. et al. ICON: food allergy//Journal of Allergy and Clinical Immunology. – 2012. – Т. 129. – № 4. – С. 906–920.
Micozzi S., Bartolomé, B., Sanchís-Merino, M. E., Alfaya, et al. Hypersensitivity to Quail Egg Proteins: What About Hen Egg?//Journal of investigational allergology & clinical immunology. – 2016. – Т. 26. – № 5. – С. 316–318.
Contreras F. J. C. et al. Allergy to quail’s egg without allergy to chicken’s egg. Case report//Allergologia et immunopathologia. – 2008. – Т. 36. – № 4. – С. 234–237.
González-Mancebo E. et al. Identification of allergens in chicken meat allergy//Journal of investigational allergology & clinical immunology. – 2011. – Т. 21. – № 4. – С. 326–327.
DiMiceli L. et al. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)//Vaccine. – 2006. – Т. 24. – № 6. – С. 703–707.
Glaxo Smith Kline. ENGERIX-B Package Insert. Mississauga, Ontario, Canada. 2013. Also, http://www .fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM224503.pdf.Accessed Aug 2016.
Merck & Co. I. RECOMBIVAX HB Package Insert. Merck, Inc. Kenilworth, NJ USA. 2014.Also, https://www.merck.com /product/usa/pi_circulars/r/recombivax_ hb/ recombivax_pi.pdf.Accessed Aug 2016.
Merck & Co. I. GARDASIL Package Insert. Merck, Inc. Kenilworth, NJ USA. 2011.Also, http://www .fda.gov/downloads/BiologicsBloodVaccines/Vaccines.
Badiu I. et al. Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80//BMJ case reports. – 2012. – Т. 2012.
Stone Jr C. A. et al. Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized//The Journal of Allergy and Clinical Immunology: In Practice. – 2018.
Wattanakrai P., Rajatanavin N. Thimerosal allergy and clinical relevance in Thailand//JOURNAL–MEDICAL ASSOCIATION OF THAILAND. – 2007. – Т. 90. – № 9. – С. 1775.
Lee-Wong M., Resnick D., Chong K. A generalized reaction to thimerosal from an influenza vaccine//Annals of Allergy, Asthma & Immunology. – 2005. – Т. 94. – № 1. – С. 90–94.
King K., Paterson M., Green S. K. Global justice and the proposed ban on thimerosal-containing vaccines // Pediatrics. – 2013. – Т. 131. – №. 1. – С. 154–156.
Russell M. et al. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS) // Vaccine. – 2004. – Т. 23. – № 5. – С. 664–667.
Stone C. A. et al. Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism // Journal of Allergy and Clinical Immunology. – 2017. – Т. 139. – № 5. – С. 1710–1713. e2.
Retterer M. K. C. et al. Specific IgE to gelatin as a cause of anaphylaxis to zoster vaccine // Journal of Allergy and Clinical Immunology. – 2018. – Т. 141. – № 5. – С. 1956–1957.
Pinson M. L., Waibel K. H. Safe administration of a gelatin-containing vaccine in an adult with galactose-α-1,3-galactose allergy // Vaccine. – 2015. – Т. 33. – № 10. – С. 1231–1232.
Jensen Jarolim E. et al. Stateoftheart in marketed adjuvants and formulations in Allergen Immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)//Allergy. – 2019.
Kelso J. M. et al. Adverse reactions to vaccines//Annals of Allergy, Asthma & Immunology. – 2009. – Т. 103. – № 4. – С. S1–S14.
American Academy of Pediatrics. Active and passive immunization//L. K. Pickeri ng, ed. Red Book: 2006 Report of the Committee on Infectious Diseases, 28th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2009.
Вакцины и вакцинация. Национальное руководство. Под ред. В. В. Зверева, Б. Ф. Семенова, Р. М. Хаитова. М.: ГЭОТАР-Медиа, 2011; 872. (Vaccines and vaccinations. National guide lines. V. V. Zverev, B. F. Semenov, R. M. Khaitov (eds). Moscow: GEOTAR-Media, 2011; 872. (in Russ).
Шамшева О. В., Учайкин В. Ф., Медуницын Н. В. Клиническая вакцинология. М: ГЭОТАР-Медиа 2016; 576. [Shamsheva O. V., Uchaykin V. F., Medunitsyn N. V. Clinical Vaccinology. Moscow: GEOTAR-Media 2016; 576. (in Russ).
Инструкция по медицинскому применению препарата. Режим доступа: http://rceth .by/NDfiles/instr/9045_94_99_04_07_09_14_s.pdf [Instructions for the medical use of the drug. http://rceth .by/NDfiles/instr/9045_94_99_04_07_09_14_s.pdf. Accessed 15.04.2020. (in Russ).
Рекомендации по проведению догоняющей иммунизации при нарушении графика профилактической иммунопрофилактики в рамках национального календаря профилактических прививок. Федеральное медико-биологическое агентство. Электронный ресурс: http://nasci .ru/?id=14285&download=1. Дата обращения 22.09.2020 г.
Dalton S. J. et al. Exacerbation of atopic dermatitis after bacillus CalmetteGuerin vaccination // Journal of the Royal Society of Medicine. – 1998. – Т. 91. – № 3. – С. 133–134.
Halsey N. A. Combination vaccines: defining and addressing current safety concerns // Clinical Infectious Diseasese. – 2001. – Т. 33. – № Supplement_4. – С. S312–S318.
Ersser S. J., Cowdell F., Latter S., Gardiner E., Flohr C., Thompson A. R., Jackson K., Farasat H., Ware F., Drury A., Ersser S. J., Cowdell F., Latter S., Gardiner E., Flohr C., Thompson A. R., Jackson K., Farasat H., Ware F., Drury A. Psychological and educational interventions for atopic eczema in children. Cochrane Database of Systematic Reviews.2014, Issue 1. Art. No.: CD004054.
Offit P. A. et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immunsystem?//Pediatrics. – 2002. – Т. 109. – № 1. – С. 124–129.